Vaccines, Blood & Biologics

RotaTeq

STN: BL 125122
Proper Name: Rotavirus Vaccine, Live, Oral, Pentavalent
Tradename: RotaTeq
Manufacturer: Merck & Co, Inc, License #0002
Indication: 

  • For prevention of rotavirus gastroenteritis in infants and children caused by the serotypes G1, G2, G3, and G4 when administered as a 3-dose series to infants between the ages of 6 to 32 weeks.

Supporting Documents

Related Information

Related Links

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 12/04/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.